LUNAI BIOWORKS INC (RENB) Stock Income Statement
USA - NASDAQ:RENB - US29350E1047 - Common Stock
1.42 USD
+0.15 (+12.16%)
1.54 USD
+0.12 (+8.45%)
| TTM (2025-3-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 19.43M | 26.19M | 19.60M | 22.83M | 23.40M | |||
| Research and Development | 891.70K | 2.71M | 4.17M | 8.37M | 15.54M | |||
| Selling, General, and Administrative Expenses | 18.88M | 23.36M | 15.32M | 14.33M | 7.74M | |||
| Operating Income | -19.43M | -26.19M | -19.60M | -22.83M | -23.40M | |||
| Interest Income/Expense | -1.90M | -2.43M | -710.00K | -250.00K | -400.00K | |||
| Other Income/Expense | 15.23M | 4.73M | 0.00 | 2.90M | -3.05M | |||
| Non Recurring Items | -60.61M | -56.75M | -19.38M | -93.25M | 0.00 | |||
| Income Before Taxes | -67.28M | -80.65M | -39.68M | -113.43M | -26.85M | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | -130.00K | |||
| Net Income | -67.28M | -80.65M | -39.68M | -113.43M | -26.72M | |||
| EBITDA | -19.31M | -26.07M | -19.49M | -22.71M | -23.28M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.44 | -8.37 | -7.05 | -21.59 | -5.66 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD